Table 2.

Incidence of adverse skin reactions according to the daily dose of imatinib [11–13]

Severity of the Rash	25–140 mg/day Imatinib (n=14)	200–300 mg/day Imatinib (n=31)	350–500 mg/day Imatinib (n=37)	600–1000 mg/day Imatinib (n=61)
Mild or moderate	7%	13%	16%	21%
Serious or life threatening	0%	0%	0%	5%